Watch the full video on Radcliffe Cardiology here: [ Ссылка ]

In this short interview, Dr James Gammie (University of Maryland Medical Center, MD, US) discusses the findings from surgical trial assessing the benefit of concomitant tricuspid repair during mitral valve surgery.
The trial, presented at AHA 2021, demonstrated that at 2 years, TA had no impact on MACCE, survival, or QOL.

Discussion Points
1. Reasoning for this Study
2. Study Design and Patient Population
3. Key Findings
4. Take-home Messages
5. Next Steps

Recorded remotely from Baltimore, 2021.

Editor: Mirjam Boros

This content is intended for healthcare professionals only.

Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.

свернуть